CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-19 | Powell Lynne Senior VP - CCO | Option exercise | +193 | $3.22 | $621 | 8,798 |
| 2018-11-19 | Powell Lynne Senior VP - CCO | Sale | −193 | $8.30 | $2K | 8,605 |
| 2018-11-19 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −193 | 122,554 | ||
| 2018-11-19 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +75 | $3.78 | $284 | 137,458 |
| 2018-11-19 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −75 | $8.30 | $623 | 137,383 |
| 2018-11-19 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −75 | 43,428 | ||
| 2018-11-08 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +11,113 | $3.22 | $36K | 148,496 |
| 2018-11-08 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −11,113 | $8.09 | $90K | 137,383 |
| 2018-11-08 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +2,302 | $3.78 | $9K | 139,685 |
| 2018-11-08 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −2,302 | $8.30 | $19K | 137,383 |
| 2018-11-08 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −11,113 | 103,571 | ||
| 2018-11-08 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −2,302 | 43,503 | ||
| 2018-11-08 | Powell Lynne Senior VP - CCO | Option exercise | +5,280 | $3.22 | $17K | 13,885 |
| 2018-11-08 | Powell Lynne Senior VP - CCO | Sale | −5,280 | $8.15 | $43K | 8,605 |
| 2018-11-08 | Powell Lynne Senior VP - CCO | Option exercise · Emp. Stock Option (Right to Buy) | −5,280 | 122,747 | ||
| 2018-11-07 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +672 | $3.22 | $2K | 138,055 |
| 2018-11-07 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −672 | $8.00 | $5K | 137,383 |
| 2018-11-07 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −672 | 114,684 | ||
| 2018-11-07 | Powell Lynne Senior VP - CCO | Option exercise | +300 | $3.22 | $966 | 8,905 |
| 2018-11-07 | Powell Lynne Senior VP - CCO | Sale | −300 | $8.00 | $2K | 8,605 |
Page 34 of 38 · 750 trades